Cogstate Limited

Stocks

CGS

AU000000CGS8

Market Closed - Australian S.E. Other stock markets 10:10:10 07/08/2026 +04			5-day change	1st Jan Change
2.590 ^AUD	-1.52%		+3.60%	+14.60%

07-08	Cogstate's June Quarter Net Sales Contracts Rises	MT
06-10	Cogstate Limited - Special Call

Transcript : Cogstate Limited - Special Call

Published on 06/10/2026 at 05:20 am +04 - Modified on 06/10/2026 at 12:35 pm +04

S&P Capital IQ

Presenter Speech
Rebecca Wilson (Attendees)

Hello, everyone, and welcome to today's webinar unlocking sustainable clinical trials growth, which is part of the Cogstate Investor Insight series. I'm

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Full unlimited browsing across the entire site

Access to all the news and all the data

Access to US, EUROPE AND ASIA Portfolios

Zero Ads for a completely uninterrupted reading experience

Pro Tools: Expert insights, Expert Screeners, historical financial data and reports, thematic lists, transcripts...

Latest news about Cogstate Limited

07-08	Cogstate's June Quarter Net Sales Contracts Rises	MT
06-10	Cogstate Limited - Special Call
05-22	Cogstate Limited Announces Changes in Joint Company Secretary Positions Effective May 22, 2026	CI
04-23	Cogstate Limited Announces Board and Committee Changes	CI
04-08	Cogstate Says Nine-Month Total Sales Contracts Reach $67.1 Million, Shares Up 6%	MT
04-08	Cogstate posts 3Q26 sales contracts executed total $25.4 million	RE
02-19	Cogstate Limited, H1 2026 Earnings Call, Feb 19, 2026
02-19	Cogstate Limited Provides Revenue Guidance for the Second Half of Fiscal Year 2026	CI
02-19	Tranche Update on Cogstate Limited's Equity Buyback Plan announced on November 11, 2025.	CI
02-19	Cogstate Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI
01-22	Cogstate Posts Higher Fiscal H1 Revenue, Clinical Trial Contract Value; Shares Up 7%	MT
01-22	Cogstate Limited Revises Earnings Guidance for the First Half Year Ended 31 December 2025	CI
12-10	Cogstate Ltd forecasts 1H26 revenue at $25-$26 million	RE
12-10	Cogstate Says Timing-Related Revenue Deferrals to Impact Fiscal Year 2026 First Half Reported Revenue, Profitability; Shares Plunge 22%	MT
12-10	Cogstate Limited Provides Earnings Guidance for the Half-Year Ending 31 December 2025	CI